GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Fisher & Paykel Healthcare Corp Ltd (NZSE:FPH) » Definitions » Gross Profit

Fisher & Paykel Healthcare (NZSE:FPH) Gross Profit : NZ$1,027 Mil (TTM As of Sep. 2023)


View and export this data going back to 1979. Start your Free Trial

What is Fisher & Paykel Healthcare Gross Profit?

Fisher & Paykel Healthcare's gross profit for the six months ended in Sep. 2023 was NZ$498 Mil. Fisher & Paykel Healthcare's gross profit for the trailing twelve months (TTM) ended in Sep. 2023 was NZ$1,027 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Fisher & Paykel Healthcare's gross profit for the six months ended in Sep. 2023 was NZ$498 Mil. Fisher & Paykel Healthcare's Revenue for the six months ended in Sep. 2023 was NZ$816 Mil. Therefore, Fisher & Paykel Healthcare's Gross Margin % for the quarter that ended in Sep. 2023 was 61.07%.

Fisher & Paykel Healthcare had a gross margin of 61.07% for the quarter that ended in Sep. 2023 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Fisher & Paykel Healthcare was 66.92%. The lowest was 54.62%. And the median was 63.43%.

Warning Sign:

Fisher & Paykel Healthcare Corp Ltd gross margin has been in long-term decline. The average rate of decline per year is -2.3%.


Fisher & Paykel Healthcare Gross Profit Historical Data

The historical data trend for Fisher & Paykel Healthcare's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fisher & Paykel Healthcare Gross Profit Chart

Fisher & Paykel Healthcare Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 717.50 845.50 1,222.60 1,013.40 945.90

Fisher & Paykel Healthcare Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 547.30 466.10 417.10 528.80 498.20

Competitive Comparison of Fisher & Paykel Healthcare's Gross Profit

For the Medical Instruments & Supplies subindustry, Fisher & Paykel Healthcare's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fisher & Paykel Healthcare's Gross Profit Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Fisher & Paykel Healthcare's Gross Profit distribution charts can be found below:

* The bar in red indicates where Fisher & Paykel Healthcare's Gross Profit falls into.



Fisher & Paykel Healthcare Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Fisher & Paykel Healthcare's Gross Profit for the fiscal year that ended in Mar. 2023 is calculated as

Gross Profit (A: Mar. 2023 )=Revenue - Cost of Goods Sold
=1588.6 - 642.7
=946

Fisher & Paykel Healthcare's Gross Profit for the quarter that ended in Sep. 2023 is calculated as

Gross Profit (Q: Sep. 2023 )=Revenue - Cost of Goods Sold
=815.8 - 317.6
=498

Gross Profit for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NZ$1,027 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Fisher & Paykel Healthcare's Gross Margin % for the quarter that ended in Sep. 2023 is calculated as

Gross Margin % (Q: Sep. 2023 )=Gross Profit (Q: Sep. 2023 ) / Revenue (Q: Sep. 2023 )
=(Revenue - Cost of Goods Sold) / Revenue
=498 / 815.8
=61.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Fisher & Paykel Healthcare  (NZSE:FPH) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Fisher & Paykel Healthcare had a gross margin of 61.07% for the quarter that ended in Sep. 2023 => Durable competitive advantage


Fisher & Paykel Healthcare Gross Profit Related Terms

Thank you for viewing the detailed overview of Fisher & Paykel Healthcare's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Fisher & Paykel Healthcare (NZSE:FPH) Business Description

Traded in Other Exchanges
Address
15 Maurice Paykel Place, East Tamaki, Auckland, NTL, NZL, 2013
Fisher & Paykel Healthcare is one of the three largest respiratory care device companies globally. It is the market leader in hospital use humidifiers, masks and related consumables and the number three player in the at-home treatment of sleep apnoea using respiratory devices. Both the hospital and homecare markets for respiratory devices are growing strongly in the developed markets in which Fisher & Paykel has a presence. The company earns 42% of its revenue in the U.S., 32% in Europe, 18% in Asia-Pacific and the remaining 8% in emerging markets. Fisher conducts its own R&D and has thousands of patents and pending applications. It manufactures in New Zealand and Mexico and has a multichannel distribution model.